{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:57:11Z","timestamp":1761101831731},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T00:00:00Z","timestamp":1187913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00117-007-1545-1","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T07:10:06Z","timestamp":1187853006000},"page":"778-784","source":"Crossref","is-referenced-by-count":10,"title":["Nephrogene systemische Fibrose"],"prefix":"10.1007","volume":"47","author":[{"given":"W.","family":"Samtleben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,24]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","volume":"15","author":"Cowper","year":"2003","unstructured":"Cowper SE (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15: 785\u2013790","journal-title":"Curr Opin Rheumatol"},{"key":"1545_CR2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2005.08.008","volume":"46","author":"Cowper","year":"2005","unstructured":"Cowper SE (2005) Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 46: 763\u2013765","journal-title":"Am J Kidney Dis"},{"key":"1545_CR3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/S0022-3476(03)00538-9","volume":"143","author":"Jan","year":"2003","unstructured":"Jan F, Segal JM, Dyer J et al. (2003) Nephrogenic fibrosing dermopathy: two pediatric cases. J Pediatr 143: 678\u2013681","journal-title":"J Pediatr"},{"key":"1545_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jvir.2007.01.025","volume":"18","author":"Chewning","year":"2007","unstructured":"Chewning RH, Murphy KJ (2007) Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency. J Vasc Interv Radiol 18: 331\u2013333","journal-title":"J Vasc Interv Radiol"},{"key":"1545_CR5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","volume":"21","author":"Grobner","year":"2006","unstructured":"Grobner T (2006) Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21: 1104\u20131108","journal-title":"Nephrol Dial Transplant"},{"key":"1545_CR6","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","volume":"17","author":"Marckmann","year":"2006","unstructured":"Marckmann P, Skov L, Rossen K et al. (2006) Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17: 2359\u20132362","journal-title":"J Am Soc Nephrol"},{"key":"1545_CR7","unstructured":"Cowper SE (2007) The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR). (NFD\/NSF Website). 2001\u20132007. Available at http:\/\/www.icnfdr.org . Accessed March 27, 2007"},{"key":"1545_CR8","unstructured":"US Food and Drug Administration. Public health advisory: Gadolinium-containing contrast agents for magnetic resonance imaging (MRI). Available at: http:\/\/www.fda.gov\/medwatch\/report\/hcp.htm . Updated 23 May 2007"},{"key":"1545_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11604-006-0055-9","volume":"24","author":"Saitoh","year":"2006","unstructured":"Saitoh T, Hayasaka K, Tanaka Y et al. (2006) Dialyzability of gadodiamide in hemodialysis patients. Radiat Med 24: 445\u2013451","journal-title":"Radiat Med"},{"key":"1545_CR10","first-page":"Epub","volume":"Transplant","author":"Marckmann","year":"2007","unstructured":"Marckmann P, Skov L, Rossen K et al. (2007) Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant: Epub","journal-title":"Nephrol Dial"},{"key":"1545_CR11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","volume":"35","author":"Mendoza","year":"2006","unstructured":"Mendoza FA, Artlett CM, Sandorfi N et al. (2006) Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35: 238\u2013249","journal-title":"Semin Arthritis Rheum"},{"key":"1545_CR12","unstructured":"Miskulin D, Gul A, Rudnik MR, Cowper SE (2007) Nephrogenic systemic fibrosis\/nephrogenic fibrosing dermopathy in advanced renal failure. UpToDate, 12. Januar 2007"},{"key":"1545_CR13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2214\/AJR.06.1094","volume":"188","author":"Broome","year":"2007","unstructured":"Broome DR, Girguis MS, Baron PW et al. (2007) Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 188: 586\u2013592","journal-title":"Am J Roentgenol"},{"key":"1545_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.rli.0000253505.88945.d5","volume":"42","author":"Khurana","year":"2006","unstructured":"Khurana A, Runge VM, Narayanan M et al. (2006) Nephrogenic systemic fibrosis. A review of 6 cases temporally related to gadodiamide injection (Omniscan). Invest Radiol 42: 139\u2013145","journal-title":"Invest Radiol"},{"key":"1545_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2005.06.024","volume":"46","author":"Daram","year":"2005","unstructured":"Daram SR, Cortese CM, Bastani B (2005) Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46: 763\u2013765","journal-title":"Am J Kidney Dis"},{"key":"1545_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00128071-200607040-00005","volume":"7","author":"Scheinfeld","year":"2006","unstructured":"Scheinfeld N (2006) Nephrogenic fibrosing dermopathy. A comprehensive review for the dermatologist. Am J Clin Dermatol 7: 237\u2013247","journal-title":"Am J Clin Dermatol"},{"key":"1545_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1525-139X.2003.16053.x","volume":"16","author":"Perazella","year":"2003","unstructured":"Perazella MA, Ishibe S, Perazella MA, Reilly RF (2003) Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial 16: 276\u2013280","journal-title":"Semin Dial"},{"key":"1545_CR18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ndt\/gfh473","volume":"20","author":"Schmook","year":"2005","unstructured":"Schmook T, Budde K, Ulrich C et al. (2005) Successfull treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 20: 220\u2013222","journal-title":"Nephrol Dial Transplant"},{"key":"1545_CR19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-4632.2007.03301.x","volume":"46","author":"Introcaso","year":"2007","unstructured":"Introcaso CE, Hivnor C, Cowper S, Werth VP (2007) Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature. Int J Dermatol 46: 447\u2013452","journal-title":"Int J Dermatol"},{"key":"1545_CR20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","volume":"356","author":"Cowper","year":"2000","unstructured":"Cowper SE, Robin HS, Steinberg SM et al. (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356: 1000\u20131001","journal-title":"Lancet"},{"key":"1545_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5858\/2006-130-209-MIINFD","volume":"130","author":"Gibson","year":"2006","unstructured":"Gibson SE, Farver CF, Prayson RA (2006) Multiorgan involvement in nephrogenic fibrosing dermopathy; an autopsy case and review of the literature. Arch Pathol Lab Med 130: 209\u2013212","journal-title":"Arch Pathol Lab Med"},{"key":"1545_CR22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","volume":"139","author":"Ting","year":"2003","unstructured":"Ting WW, Stone MA, Madison KC, Murtz K (2003) Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139: 903\u2013906","journal-title":"Arch Dermatol"},{"key":"1545_CR23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.0307-6938.2004.01474.x","volume":"29","author":"Gambichler","year":"2003","unstructured":"Gambichler T, Paech V, Kreuter A et al. (2003) Nephrogenic fibrosing dermopathy. Clin Exp Dermatol 29: 258\u2013260","journal-title":"Clin Exp Dermatol"},{"key":"1545_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000078587","volume":"209","author":"Hauser","year":"2004","unstructured":"Hauser C, Kaya G, Chizzolini C (2004) Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis. Dermatology 209: 50\u201352","journal-title":"Dermatology"},{"key":"1545_CR25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000372-200110000-00001","volume":"23","author":"Cowper","year":"2001","unstructured":"Cowper SE, Su LD, Bhawan J et al. (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23: 383\u2013393","journal-title":"Am J Dermatopathol"},{"key":"1545_CR26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(03)00085-8","volume":"114","author":"Swartz","year":"2003","unstructured":"Swartz RD, Crofford LJ, Phan SH et al. (2003) Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114: 563\u2013572","journal-title":"Am J Med"},{"key":"1545_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00004424-199610000-00003","volume":"31","author":"Puttagunta","year":"1996","unstructured":"Puttagunta NR, Gibby W, Puttagunta V (1996) Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Invest Radiol 31: 619\u2013624","journal-title":"Invest Radiol"},{"key":"1545_CR28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1472-8206.2006.00447.x","volume":"20","author":"Idee","year":"2006","unstructured":"Idee J, Port M, Raynal I et al. (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20: 563\u2013576","journal-title":"Fundam Clin Pharmacol"},{"key":"1545_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","volume":"5","author":"Joffe","year":"1998","unstructured":"Joffe P, Thomsen HS, Meusel M (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5: 491\u2013502","journal-title":"Acad Radiol"},{"key":"1545_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","volume":"56","author":"High","year":"2007","unstructured":"High WA, Ayers RA, Chandler J et al. (2007) Gadolinium is detectable within the tissues of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 21\u201326","journal-title":"J Am Acad Dermatol"},{"key":"1545_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","volume":"56","author":"Boyd","year":"2007","unstructured":"Boyd AS, Zik JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermatopathy. J Am Acad Dermatol 56: 27\u201330","journal-title":"J Am Acad Dermatol"},{"key":"1545_CR32","first-page":"437","volume":"18","author":"Behra-Milliet","year":"1996","unstructured":"Behra-Milliet J, Gressier B, Brunet C et al. (1996) Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability. Methods Find Exp Clin Pharmacol 18: 437\u2013442","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"1545_CR33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2005.06434.x","volume":"152","author":"Gilliet","year":"2005","unstructured":"Gilliet M, Cozzio A, Burg G, Nestle FO (2005) Successful treatment of three cases of nephrogenic fibrosing dermatopathy with extracorporeal photopheresis. Br J Dermatol 152: 531\u2013536","journal-title":"Br J Dermatol"},{"key":"1545_CR34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000077321","volume":"208","author":"L\u00e4uchli","year":"2004","unstructured":"L\u00e4uchli S, Zortea-Caflisch C, Nestle FO et al. (2004) Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 208: 278\u2013280","journal-title":"Dermatology"},{"key":"1545_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00000372-200306000-00004","volume":"25","author":"Baron","year":"2003","unstructured":"Baron P, Cantos K, Hillebrand DJ et al. (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatol 25: 204\u2013209","journal-title":"Am J Dermatol"},{"key":"1545_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2133.2003.05181.x","volume":"148","author":"Hubbard","year":"2003","unstructured":"Hubbard V, Davenport A, Jarmulowicz M, Rustin M (2003) Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 148: 563\u2013568","journal-title":"Br J Dermatol"},{"key":"1545_CR37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2133.2003.05795.x","volume":"150","author":"Chung","year":"2004","unstructured":"Chung HJ, Chung KY (2004) Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin. Br J Dermatol 150: 596\u2013597","journal-title":"Br J Dermatol"},{"key":"1545_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"16","author":"Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Int Med 16: 461\u2013470","journal-title":"Ann Int Med"},{"key":"1545_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31\u201341","journal-title":"Nephron"},{"key":"1545_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/028418501127346756","volume":"42","author":"Okada","year":"2001","unstructured":"Okada S, Katagiri K, Kumazaki T, Yokoyama H (2001) Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol 42: 339\u2013341","journal-title":"Acta Radiol"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-007-1545-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-007-1545-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-007-1545-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T05:48:25Z","timestamp":1629611305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-007-1545-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,24]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1007\/s00117-007-1545-1","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,24]]}}}